PTAB

Patent Trial and Appeal Board decisions

PTAB, Utility Patent

ResMed Corp. v. Cleveland Medical Devices — PTAB Issues Split Decision, Invalidating One Sleep Apnea Patent and Upholding Another

The Patent Trial and Appeal Board issued a split final written decision in a pair of inter partes review proceedings filed by ResMed Corp., finding one Cleveland Medical Devices sleep apnea treatment patent unpatentable while upholding claims in a closely related companion patent, illustrating the all-or-nothing stakes of IPR litigation on patent families.

PTAB, Utility Patent

Xilinx v. Analog Devices — Federal Circuit on IPR Petition Grounds and Institution of Partial Review

The Federal Circuit addressed the PTAB’s discretionary authority under § 314(a) to deny IPR petitions based on factors including the stage of parallel district court litigation and the efficiency of institution — affirming the PTAB’s broad discretion in institution decisions and its authority to consider the NHK-Fintiv framework for balancing IPR efficiency against parallel litigation.

Scroll to Top